Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;70(11):1313-24.
doi: 10.1007/s00228-014-1748-0. Epub 2014 Sep 13.

Breastfeeding and migraine drugs

Affiliations
Review

Breastfeeding and migraine drugs

Riccardo Davanzo et al. Eur J Clin Pharmacol. 2014 Nov.

Abstract

Purpose: Breastfeeding women may suffer from migraine. While we have many drugs for its treatment and prophylaxis, the majority are poorly studied in breastfeeding women. We conducted a review of the most common anti-migraine drugs (AMDs) and we determined their lactation risk.

Methods: For each AMD, we collected all retrievable data from Hale's Medications and Mother Milk (2012), from the LactMed database (2014) of the National Library of Medicine, and from a MedLine Search of relevant studies published in the last 10 years.

Results: According to our review, AMDs safe during breastfeeding are as follows: low-dose acetylsalicylic acid (ASA), ibuprofen, sumatriptan, metoprolol, propranolol, verapamil, amitriptyline, escitalopram, paroxetine, sertraline, acetaminophen, caffeine, and metoclopramide. AMDs compatible with breastfeeding but warranting caution are as follows: diclofenac, ketoprofen, naproxen, most new triptans, topiramate, valproate, venlafaxine, and cyproheptadine. Finally, high-dose ASA, atenolol, nadolol, cinnarizine, flunarizine, ergotamine, methysergide, and pizotifen are contraindicated.

Conclusions: According to our review, the majority of the revised AMDs were assessed to be compatible with breastfeeding.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Pharmacol. 2010 Nov;50(11):1301-9 - PubMed
    1. Am J Obstet Gynecol. 1974 Sep;120(1):129-31 - PubMed
    1. Eur J Clin Pharmacol. 2010 Sep;66(9):855-8 - PubMed
    1. Intern Med. 2012;51(22):3119-23 - PubMed
    1. J Pediatr Endocrinol Metab. 2009 May;22(5):425-32 - PubMed

MeSH terms

-